3-Dimensional Pharmaceuticals and Johnson & Johnson enter drug discovery alliance

3-Dimensional Pharmaceuticals has formed a drug discovery alliance to discover and optimize small molecule drug leads directed to genomics targets identified by Johnson & Johnson Pharmaceutical Research & Development.

Published By MarketLine

3-Dimensional Pharmaceuticals Announces Financial Results For The Quarter And Year Ended December 31, 2000

Published By MarketLine

3-Dimensional Pharmaceuticals Announces Financial Results For the Quarter Ended March 31, 2001

Published By MarketLine

3-Dimensional Pharmaceuticals extends research funding on thrombin collaboration

3-Dimensional Pharmaceuticals is to extend its thrombin research collaboration with Centocor and Johnson & Johnson Pharmaceutical R&D, both members of the Johnson & Johnson family of companies.<BR /><BR />

Published By MarketLine

3-Dimensional Pharmaceuticals licenses GlaxoSmithKline's investigational low blood platelet treatment

3-Dimensional Pharmaceuticals has entered into an exclusive licensing agreement with GlaxoSmithKline, giving it worldwide development, marketing and distribution rights to GlaxoSmithKline's pre-Investigational New Drug application compound GW 395058 for the prevention and treatment of thrombocytopenia, or low blood platelet count.<BR />

Published By MarketLine

3-V Biosciences appoints new CEO

3-V Biosciences, a biopharmaceutical company, has appointed Merdad Parsey as new CEO.

Published By MarketLine

3-V Biosciences appoints new chief business officer

3-V Biosciences, Inc., a privately-held biopharmaceutical company, has appointed Stephen Brady as chief business officer.

Published By MarketLine

3-V Biosciences appoints new chief medical officer

3-V Biosciences, a biopharmaceutical company, has appointed Edward Connor, Jr, as chief medical officer.

Published By MarketLine

3A Pharma to replace legacy ERP system with Compiere ERP

Compiere, a US-based provider of open source and cloud-based ERP solutions, has announced that Vietnam-based pharmaceutical distributor, 3A Pharma, will replace its ERP system with Compiere ERP in order to optimize the company's distribution operations.

Published By MarketLine

3D Biotek appoints senior executive vice president

3D Biotek , a biotechnology company, has appointed James Fay as senior executive vice president and a member of its management leadership team.

Published By MarketLine